BioAtla (BCAB) Interest & Investment Income (2020 - 2026)
BioAtla's (BCAB) quarterly Interest & Investment Income came in at $37000.0 in Q1 2026, down 90.75% year-on-year from $400000.0 in Q1 2025, and down 49.32% quarter-over-quarter from $73000.0 in Q4 2025.
BioAtla (BCAB) Interest & Investment Income (2020 - 2026) Analysis & Trends
BioAtla's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $37000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 90.75% year-over-year to $37000.0 in Q1 2026; TTM through Mar 2026 was $476000.0, a 81.3% decrease from a year earlier, with the FY2025 full-year figure at $843000.0, down 74.98% from the prior year.
- Interest & Investment Income declined to $37000.0 in Q1 2026 per BCAB's latest filing, from $73000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.7 million in Q3 2023 and bottomed at $37000.0 in Q1 2026.
- The 5-year median for Interest & Investment Income is $554000.0 (2024), against an average of $717941.2.
- Across the five-year window, Interest & Investment Income soared 1641.18% in 2023 and slumped 90.75% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $1.0 million in 2022, then surged by 56.45% to $1.6 million in 2023, then slumped by 66.18% to $554000.0 in 2024, then slumped by 86.82% to $73000.0 in 2025, then sank by 49.32% to $37000.0 in 2026.
- Per Business Quant, the three latest BCAB Interest & Investment Income figures stand at $37000.0 (Q1 2026), $73000.0 (Q4 2025), and $133000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | BioAtla | 5.08 Mn | 5.08 Mn | - | 37,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,000.00 |
| Dec 31, 2025 | 73,000.00 |
| Sep 30, 2025 | 133,000.00 |
| Jun 30, 2025 | 233,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 554,000.00 |
| Sep 30, 2024 | 692,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 370,000.00 |
| Jun 30, 2022 | 146,000.00 |
| Mar 31, 2022 | 85,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Jun 30, 2021 | 80,000.00 |